Compounds > 1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide
Page last updated: 2024-08-25

1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide and Machado-Joseph Disease

1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide has been researched along with Machado-Joseph Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Z; Hou, X; Jiang, H; Peng, H; Peng, L; Qiu, R; Shen, L; Shi, Y; Tang, B; Tang, Z; Wan, L; Wang, C; Xia, K; Zou, G1

Other Studies

1 other study(ies) available for 1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide and Machado-Joseph Disease

ArticleYear
Characterization of the central motor conduction time in a large cohort of spinocerebellar ataxia type 3 patients.
    Parkinsonism & related disorders, 2022, Volume: 104

    Topics: Evoked Potentials, Motor; Humans; Machado-Joseph Disease; Neural Conduction; Transcranial Magnetic Stimulation

2022